Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays - Chayoua, W; Kelchtermans, H; Moore, G W (J Thromb Haemost, 2018)